Kevin Pollack - Net Worth and Insider Trading
Kevin Pollack Net Worth
The estimated net worth of Kevin Pollack is at least $7 dollars as of 2024-11-13. Kevin Pollack is the Director of Pressure BioSciences Inc and owns about 583 shares of Pressure BioSciences Inc (PBIO) stock worth over $4. Kevin Pollack is the Director of Taronis Fuels Inc and owns about 36,487 shares of Taronis Fuels Inc (TRNFQ) stock worth over $4. Kevin Pollack is also the Director of BBHC Inc and owns about 88 shares of BBHC Inc (TRNX) stock worth over $0. Details can be seen in Kevin Pollack's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin Pollack has not made any transactions after 2020-03-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kevin Pollack
Kevin Pollack Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin Pollack owns 4 companies in total, including Pressure BioSciences Inc (PBIO) , Taronis Fuels Inc (TRNFQ) , and BBHC Inc (TRNX) among others .
Click here to see the complete history of Kevin Pollack’s form 4 insider trades.
Insider Ownership Summary of Kevin Pollack
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PBIO | Pressure BioSciences Inc | 2013-08-30 | director |
| TRNFQ | Taronis Fuels Inc | 2020-03-30 | director |
| TRNX | BBHC Inc | 2019-11-21 | director |
 | | 2014-12-10 | director & 10 percent owner & Chief Financial Officer |
Kevin Pollack Latest Holdings Summary
Kevin Pollack currently owns a total of 3 stocks. Among these stocks, Kevin Pollack owns 583 shares of Pressure BioSciences Inc (PBIO) as of August 30, 2013, with a value of $4 and a weighting of 50.89%. Kevin Pollack owns 36,487 shares of Taronis Fuels Inc (TRNFQ) as of March 30, 2020, with a value of $4 and a weighting of 49%. Kevin Pollack also owns 88 shares of BBHC Inc (TRNX) as of December 15, 2017, with a value of $0 and a weighting of 0.12%.
Latest Holdings of Kevin Pollack
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PBIO | Pressure BioSciences Inc | 2013-08-30 | 583 | 0.01 | 4 |
| TRNFQ | Taronis Fuels Inc | 2020-03-30 | 36,487 | 0.00 | 4 |
| TRNX | BBHC Inc | 2017-12-15 | 88 | 0.00 | 0 |
Holding Weightings of Kevin Pollack
Kevin Pollack Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin Pollack has made a total of 0 transactions in Pressure BioSciences Inc (PBIO) over the past 5 years. The most-recent trade in Pressure BioSciences Inc is the acquisition of 250 shares on August 30, 2013, which cost Kevin Pollack around $2,100.
According to the SEC Form 4 filings, Kevin Pollack has made a total of 1 transactions in Taronis Fuels Inc (TRNFQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Taronis Fuels Inc is the acquisition of 1,449 shares on March 30, 2020, which cost Kevin Pollack around $9,783.
According to the SEC Form 4 filings, Kevin Pollack has made a total of 0 transactions in BBHC Inc (TRNX) over the past 5 years. The most-recent trade in BBHC Inc is the acquisition of 72 shares on December 15, 2017, which cost Kevin Pollack around $31,417.
Insider Trading History of Kevin Pollack
- 1
Kevin Pollack Trading Performance
GuruFocus tracks the stock performance after each of Kevin Pollack's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin Pollack is -16.19%. GuruFocus also compares Kevin Pollack's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin Pollack within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kevin Pollack's insider trading performs compared to the benchmark.
Performance of Kevin Pollack
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.55 | | | | | |
| Relative Return to S&P 500(%) | -0.45 | | | | | |
Kevin Pollack Ownership Network
Ownership Network List of Kevin Pollack
Ownership Network Relation of Kevin Pollack
Kevin Pollack Owned Company Details
What does Pressure BioSciences Inc do?
Who are the key executives at Pressure BioSciences Inc?
Kevin Pollack is the director of Pressure BioSciences Inc. Other key executives at Pressure BioSciences Inc include Senior Vice President & CFO Daniel Joseph Shea , Chief Commercial Officer Bradford Addison Young , and director & Chief Executive Officer Richard T Schumacher .
Pressure BioSciences Inc (PBIO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Pressure BioSciences Inc (PBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pressure BioSciences Inc (PBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Pressure BioSciences Inc (PBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pressure BioSciences Inc Insider Transactions
Kevin Pollack Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin Pollack. You might contact Kevin Pollack via mailing address: 150 Rainville Road, Tarpon Springs Fl 34689.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
